Leave a Reply

Next Post

CanSino to start Phase III trial of COVID-19 vaccine in Saudi

FILE PHOTO: Chinese vaccine maker CanSino Biologics’ sign is pictured on its building in Tianjin, China November 20, 2018. REUTERS/Stringer/File Photo August 9, 2020 DUBAI (Reuters) – Saudi Arabia will soon begin Phase III clinical trials on around 5,000 people for a COVID-19 vaccine developed by China’s CanSino Biologics Inc, […]

You May Like